000830:SZSELuxi Chemical Group Co., Ltd. Analysis
Data as of 2026-05-21 - not real-time
CN¥13.43
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Luxi Chemical is trading at CNY 13.43, barely above its 30‑day support of CNY 13.40 and well below the 20‑day SMA of 15.66, indicating limited upside in the near term. The RSI of 26 signals an oversold condition, while the MACD remains bearish, suggesting a fragile price recovery. Volatility is high at 47% over the past month and beta is slightly negative, reflecting a stock that is not moving in tandem with the broader market, which adds to short‑term uncertainty.
Fundamentally, the company posted a 2.4% revenue decline, thin gross margin of 9.2% and operating margin of 8.9%, and carries a debt‑to‑equity ratio of 60%, highlighting balance‑sheet pressure. Despite a dividend yield of 2.5% and a payout ratio of 71%, free cash flow remains modest, raising questions about dividend sustainability. The DCF fair value of roughly CNY 2.1 is far below the current price, implying the stock is overvalued relative to intrinsic estimates, even though analyst targets suggest modest upside.
Fundamentally, the company posted a 2.4% revenue decline, thin gross margin of 9.2% and operating margin of 8.9%, and carries a debt‑to‑equity ratio of 60%, highlighting balance‑sheet pressure. Despite a dividend yield of 2.5% and a payout ratio of 71%, free cash flow remains modest, raising questions about dividend sustainability. The DCF fair value of roughly CNY 2.1 is far below the current price, implying the stock is overvalued relative to intrinsic estimates, even though analyst targets suggest modest upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in oversold territory suggests potential bounce
- Price hovering just above key support level
- Bearish MACD histogram indicates downside pressure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction and high debt burden
- Current price still below SMA50 and SMA200
- Dividend yield attractive but sustainability concerns
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- DCF valuation indicates significant overpricing
- Persistent margin compression and weak growth outlook
- Elevated volatility and sector cyclicality
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin3.22%
P/E Ratio27.4
ROE4.81%
ROA1.91%
Debt/Equity60.25
P/B Ratio1.3
Op. Cash FlowCN¥3.4B
Free Cash FlowCN¥1.2B
Technical Analysis
TrendNeutral
RSI26.0
SupportCN¥13.40
ResistanceCN¥17.35
MA 20CN¥15.66
MA 50CN¥16.37
MA 200CN¥15.44
MACDBearish
VolumeDecreasing
Fear & Greed Index90.5
Valuation
Fair ValueCN¥2.09
Target PriceCN¥22.90
Upside/Downside70.51%
GradeOvervalued
TypeValue
Dividend Yield2.51%
Risk Assessment
Beta-0.27
Volatility47.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.